TOMM40 and Parkinson disease: Moreover, decreased levels of TOM40 protein were also observed in the brains of the α-Syn transgenic mouse model of PD, when compared to non-transgenic littermates, with no overt changes on TOM20 levels (Figure 1 E–H), decays that also corresponded with α-Syn-overexpression.